Doubling the deck

Abstract

Comment on: Lv L, et al. Cell Cycle 2012; 11:2864-75.

Keywords: :

• aneuploidy
• tetraploidy
• tumorigenesis
• cytokinesis failure
• chromosome mis-segregation

This article refers to:

Tetraploid cells from cytokinesis failure induce aneuploidy and spontaneous transformation of mouse ovarian surface epithelial cells

Aneuploidy is ubiquitous in cancer and has been causally linked to tumorigenesis.¹ Although many decades of intense research have provided invaluable information on the causes and consequences of aneuploidy (reviewed in ref. 1), many questions still remain. For example, it is still unclear whether the degree of aneuploidy observed in cancer is the result of multiple subsequent losses/gains of one to few chromosomes, or if it is the result of an initial tetraploidization event followed by chromosome loss/gain events.² Furthermore, although tetraploidy has been observed in certain pre-cancerous lesions, thus making it a potential tumor promoter, it is not clear how tetraploidy affects aneuploidization and tumorigenesis.¹ In a recent study, Lv, et al. began to provide answers to these questions by characterizing the karyotypes and cell division defects of mouse ovarian surface epithelial (MOSE) cells, which spontaneously transform after in vitro passaging over time.³ Lv, et, al. showed that the rate of cytokinesis failure in MOSE cells increases with passage number, yielding more tetraploid cells.³ These tetraploid cells continue to proliferate, but they display higher rates of chromosome mis-segregation compared to their diploid progenitors, leading to the generation of numerous aneuploid daughter cells.³ Recent studies showing that clustering of supernumerary centrosomes is a major cause of chromosome mis-segregation^4-6 support the findings of Lv, et al. To investigate how the observed cellular events affect tumorigenesis, Lv, et al. injected late-passage (p35) MOSE cells into syngenic mice and saw tumors in 100% of mice.³ The rapid transformation of MOSE cells with the concurrent generation of aneuploidy underscores the importance of aneuploidy in tumorigenesis. Indeed, it may be more appropriate to describe the transformation of MOSE cells as aneuploidy-induced instead of spontaneous, since passaging of chromosomally stable immortalized cells for a similar amount of time does not result in tumorigenesis.⁶ Similar to the study by Lv, et al., previous work in mouse mammary epithelial cells showed the same sequence of events: cytokinesis failure-tetraploidy-aneuploidy-tumorigenesis.⁷ However, unlike the work by Lv, et al., this sequence of events in mouse mammary epithelial cells relied upon p53 mutation or loss.⁷ It is unclear whether or not this is true for the MOSE cells used by Lv, et al. Preliminary microarray data indicate a decrease in p53 expression levels in MOSE cells during progression (Schmelz, personal communication), but loss of p53 in MOSE cells has not been reported to date. Thus, it is unlikely that p53 was spontaneously lost in the Lv, et al. and other independent studies using MOSE cells,⁸ adding to the controversy of a “tetraploidy checkpoint.”⁹ While more work may be needed to understand whether p53 plays any role in modulating a response to tetraploidy and in the MOSE cancer progression model, it is clear from the work by Lv, et al. that tetraploidy can occur early in tumorigenesis, act as an intermediate for aneuploidization and, ultimately, cause cancer (Fig. 1).³

Figure 1. Tetraploidy can act as an intermediate for aneuploidization and cause cancer. Cells undergoing normal cytokinesis (A) maintain a stable karyotype and exhibit normal growth. Cytokinesis failure (B) generates tetraploid cells whose karyotype becomes unstable due to high rates of chromosome segregation errors. Such instability leads to high rates of aneuploidy and tumorigenesis.